Table 2.
Group | Dose (g/kg) | Initial weight | Weight at week 1 | Weight at week 2 | Weight at week 3 |
---|---|---|---|---|---|
Blank group | – | 169.3 ± 12.2 | 213.8 ± 31.3 | 268.6 ± 40.3 | 300.5 ± 40.1* |
Model group | – | 165.6 ± 8.7 | 203.5 ± 14.1 | 249.1 ± 21.4 | 272.3 ± 21.8 |
CH group | 0.02 | 166.7 ± 9.2 | 206.2 ± 18.9 | 255.5 ± 22.7 | 288.8 ± 21.9 |
FLR group | 2.4 | 167.4 ± 12.6 | 205.2 ± 25.4 | 261.4 ± 28.4 | 297.3 ± 28.8* |
1.8 | 169.6 ± 11.1 | 207.6 ± 28.1 | 260.1 ± 31.6 | 287.8 ± 30.5 | |
1.2 | 170.1 ± 10.2 | 211.4 ± 19.6 | 261.1 ± 29.4 | 300.2 ± 26.7* |
Note: **Represent compared to the model group P < 0.01; CH group: clomipramine hydrochloride group, FLR group: Baihe Dihuang powder group.
Represent Compared to the model group P < 0.05.